Horizontal platform supported hip replacement.
The cementless horizontal platform supported femoral component for hip replacement was designed to provide physiologic stress loading of the proximal femur after hip replacement. The goal is to extend pain-free implant survival by reducing periprosthetic bone resorption and to provide improved hip function and many years of relief from hip pain. A total hip replacement using this prosthesis was done in 334 consecutive nonselective hips in 322 patients. The mean age of the patients at the time of total hip replacement was 69 years (range, 29-89 years). Thirty-two patients (34 hips) were lost to followup and 81 patients (83 hips) died less than 10 years postoperatively. The remaining 209 patients (217 hips) were followed up for a minimum of 10 years (maximum, 14 years). There were six revisions of the femoral prosthesis. Three (1.8%) were revised for loosening, two were revised for femoral fracture, and one was revised for unexplained pain. The rate of stem survival was 0.97 +/- 0.02 (mean and standard error). There were 209 (96%) hips with excellent or good results. Seven (3%) patients had osteolytic changes develop. Radiographic evidence of diminished bone density in the proximal femur was seen in 34 hips (16%). The clinical results are comparable with other reported results for cementless hip replacements at 10 years.